v3.24.3
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 174,579 $ 69,268
Marketable securities 213,675 264,413
Investment in equity securities 0 41,937
Accounts receivable 6,655 36,078
Prepaid expenses and other current assets 10,870 9,846
Total current assets 405,779 421,542
Property and equipment, net 18,997 21,940
Operating lease right-of-use assets 19,027 22,815
Other non-current assets 7,172 3,567
Restricted cash 857 872
Total assets 451,832 470,736
Current liabilities:    
Accounts payable 6,216 9,440
Accrued compensation 13,177 14,686
Deferred revenue—current 72,560 20,666
Operating lease liability - current 7,203 6,420
Debt—current   4,061
Accrued expenses and other current liabilities 32,135 38,473
Total current liabilities 131,291 93,746
Deferred revenue - non-current 17,999 53,379
Operating lease liability - non-current 17,661 23,154
Deferred royalty obligation related to the sale of future royalties 171,967 149,114
Other non-current liabilities 1,694 1,694
Total liabilities 340,612 321,087
Commitments and contingencies (Note 6)
Stockholders’ equity:    
Preferred stock, $0.001 par value - 10,000,000 shares authorized as of September 30, 2024 and December 31, 2023; no shares issued and outstanding as of September 30, 2024 and December 31, 2023
Common stock, $0.001 par value - 300,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 82,395,350 and 61,009,829 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 82 61
Additional paid-in-capital 825,458 708,975
Accumulated other comprehensive (loss) income 106 21
Accumulated deficit (714,426) (559,408)
Total stockholders’ equity 111,220 149,649
Total Liabilities and Stockholders’ Equity $ 451,832 $ 470,736

Source